中国组织工程研究与临床康复
中國組織工程研究與臨床康複
중국조직공정연구여림상강복
JOURNAL OF CLINICAL REHABILITATIVE TISSUE ENGINEERING RESEARCH
2010年
18期
3262-3266
,共5页
霍文谦%靳风烁%聂志林%李黔生%朱方强%张克勤
霍文謙%靳風爍%聶誌林%李黔生%硃方彊%張剋勤
곽문겸%근풍삭%섭지림%리검생%주방강%장극근
肾损伤分子1%肾移植%肾功能%诊断%器官移植
腎損傷分子1%腎移植%腎功能%診斷%器官移植
신손상분자1%신이식%신공능%진단%기관이식
背景:肾损伤分子1已被证实是一种诊断急性肾缺血损伤的特异性分子并参与肾损伤修复过程,研究表明肾损伤分子1可作为诊断移植肾肾小管上皮细胞损伤的标志物,但其在早期移植肾功能恢复过程中动态表达的意义尚未见报道.目的:观察肾移植后尿肾损伤分子1含量和早期肾功能恢复的关系,为临床更好地评估及预测移植肾功能恢复能力提供依据.方法:纳入46例肾移植受者,根据早期肾功能恢复情况分为3组,肾功能迅速恢复组22例,肾功能缓慢恢复组14例,肾功能延迟恢复组10例.肾移植后2周内每_犬收集24 h尿液标本,用ELISA方法检测尿液肾损伤分子1含量,同时检测尿液肌酐浓度和当天血清肌酐浓度.观察肾功能恢复过程中尿肾损伤分子1含量变化,并分析尿肾损伤分子1含量和血清肌酐浓度变化的关系.结果与结论:各组肾移植后2 d内尿肾损伤分子1含量处于高水平状态,组间差异无显著性意义(P>0.05).肾移植2 d后肾功能迅速恢复组尿肾损伤分子1含量随肌酐的下降而讯速下降;肾功能缓慢恢复组尿肾损伤分子1含量持续处于高水平状态,肌酐正常后开始下降:肾功能延迟恢复组尿肾损伤分子1含量迅速下降,但在肌酐开始下降的前一两天迅速上升并持续到肌酐恢复正常.提示尿肾损伤分子1动态检测对预测肾移植后肾功能恢复有重要意义,肾损伤分子1水平高可能预示肾功能的恢复.
揹景:腎損傷分子1已被證實是一種診斷急性腎缺血損傷的特異性分子併參與腎損傷脩複過程,研究錶明腎損傷分子1可作為診斷移植腎腎小管上皮細胞損傷的標誌物,但其在早期移植腎功能恢複過程中動態錶達的意義尚未見報道.目的:觀察腎移植後尿腎損傷分子1含量和早期腎功能恢複的關繫,為臨床更好地評估及預測移植腎功能恢複能力提供依據.方法:納入46例腎移植受者,根據早期腎功能恢複情況分為3組,腎功能迅速恢複組22例,腎功能緩慢恢複組14例,腎功能延遲恢複組10例.腎移植後2週內每_犬收集24 h尿液標本,用ELISA方法檢測尿液腎損傷分子1含量,同時檢測尿液肌酐濃度和噹天血清肌酐濃度.觀察腎功能恢複過程中尿腎損傷分子1含量變化,併分析尿腎損傷分子1含量和血清肌酐濃度變化的關繫.結果與結論:各組腎移植後2 d內尿腎損傷分子1含量處于高水平狀態,組間差異無顯著性意義(P>0.05).腎移植2 d後腎功能迅速恢複組尿腎損傷分子1含量隨肌酐的下降而訊速下降;腎功能緩慢恢複組尿腎損傷分子1含量持續處于高水平狀態,肌酐正常後開始下降:腎功能延遲恢複組尿腎損傷分子1含量迅速下降,但在肌酐開始下降的前一兩天迅速上升併持續到肌酐恢複正常.提示尿腎損傷分子1動態檢測對預測腎移植後腎功能恢複有重要意義,腎損傷分子1水平高可能預示腎功能的恢複.
배경:신손상분자1이피증실시일충진단급성신결혈손상적특이성분자병삼여신손상수복과정,연구표명신손상분자1가작위진단이식신신소관상피세포손상적표지물,단기재조기이식신공능회복과정중동태표체적의의상미견보도.목적:관찰신이식후뇨신손상분자1함량화조기신공능회복적관계,위림상경호지평고급예측이식신공능회복능력제공의거.방법:납입46례신이식수자,근거조기신공능회복정황분위3조,신공능신속회복조22례,신공능완만회복조14례,신공능연지회복조10례.신이식후2주내매_견수집24 h뇨액표본,용ELISA방법검측뇨액신손상분자1함량,동시검측뇨액기항농도화당천혈청기항농도.관찰신공능회복과정중뇨신손상분자1함량변화,병분석뇨신손상분자1함량화혈청기항농도변화적관계.결과여결론:각조신이식후2 d내뇨신손상분자1함량처우고수평상태,조간차이무현저성의의(P>0.05).신이식2 d후신공능신속회복조뇨신손상분자1함량수기항적하강이신속하강;신공능완만회복조뇨신손상분자1함량지속처우고수평상태,기항정상후개시하강:신공능연지회복조뇨신손상분자1함량신속하강,단재기항개시하강적전일량천신속상승병지속도기항회복정상.제시뇨신손상분자1동태검측대예측신이식후신공능회복유중요의의,신손상분자1수평고가능예시신공능적회복.
BACKGROUND: Urinary kidney injury molecule-1 (KIM-1) has been proved to be a novel kidney-specific injury molecule as a marker for the diagnosis of acute renal ischemia injury, and KIM-1 participated in the progress of renal injury repair. However, no one reported the significance of its dynamic expression during the functional rehabilitation of renal graft.OBJECTIVE: To investigate the relations between urinary KIM-1 level and the early renal graft function in order to provide rational approaches for evaluating or predicting early renal graft function.METHODS: The 46 patients were divided into 3 groups, including 22 cases of immediate graft function (IGF), 14 cases of slow graft function (SGF) and 10 cases of delayed graft function (DGF). The 24-hour urine specimen was collected every day for 2 weeks since the operation. The urinary KIM-1 content was detected by enzyme linked immunosorbent assay (ELISA), and at the same time the urinary and serum creatinine levels were detected. The diversity of urinary KIM-1 level was observed during the recovery of the graft function, and the clinical significance was evaluated by analyzing the correlation of urinary KIM-1 level and serum creatinine.RESULTS AND CONCLUSION: At the first 2 days after kidney transplantation, the urinary KIM-1 levels were high and no significant difference was observed between the three groups (P < 0.05). Two days later, the urinary KIM-1 level descended quickly along with the descent of the serum creatinine in IGF and SGF groups; the urinary KIM-1 maintained high levels until the serum creatinine reached normally. In DGF group, the urinary KIM-1 decreased quickly to a low level after 2 days from operation, but it increased promptly 1 to 2 days before the recovery of graft function and kept a high level until the serum creatinine reached normally. This suggested that consecutive detection of urinary KIM-1 is useful for monitoring the early graft function after kidney transplantation, and high urinary KIM-1 may suggest the recovery of graft function.